Elucid Announces Broad Reimbursement for Quantitative Coronary Plaque Analysis

Elucid today announced that, effective January 1, 2026, its Plaque-IQ(TM) coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT(R)) designation, alongside ...

CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy

“We believe the new Category I CPT codes will enable more predictable and consistent reimbursement for Barostim patients and healthcare professionals,” said Kevin Hykes, President and Chief Executive ...

PolarityBio Announces AMA Publication of New Category III CPT Codes for SkinTE(R) Procedures

SkinTE is currently available for investigational use only. Submission of a biologics license application (BLA) to the U.S. Food and Drug Administration is expected in 2026, after which additional ...

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

This coverage milestone follows the American Medical Association’s recent implementation of the new Category I Current Procedural Terminology (CPT ®) payment code 75577 for Heartflow Plaque Analysis, ...
Rheumatology Advisor

VA/DoD Recommendations Updated for Primary Care Management of CKD

“The VA/DoD CPG provides primary care clinicians with up-to-date practical recommendations for accurately staging CKD, predicting progression to kidney failure, and using pharmacotherapies to prevent ...
Nature

Cardiovascular diseases articles from across Nature Portfolio

A phase 3 trial shows no impact of the anticoagulant rivaroxaban on the risk of cognitive decline in individuals with atrial fibrillation and low thromboembolic risk — highlighting the need for a ...